We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.

Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

People who have been using Ozempic have been complaining of a bizarre side-effect, which has been nicknamed 'Ozempic butt'.

Federal agents were able to nab about 30 well-known criminal aliens in New York City on Tuesday all thanks to the Trump Administration’s “recommitment to do more to protect our cities ...

Is Said to Discuss Dropping Case Against Eric Adams Officials under President Trump talked with Manhattan prosecutors about possibly abandoning the corruption case against the mayor of New York City.